TTF-1 Expression and Clinical Outcomes of Combined Chemoimmunotherapy in Patients With Advanced Lung Adenocarcinoma: A Prospective Observational Study.

Katayama Y, Yamada T, Morimoto K, Fujii H, Morita S, Tanimura K, Takeda T, Okada A, Shiotsu S, Chihara Y, Hiranuma O, Yamada T, Ota T, Harada T, Hasegawa I, Yoshimura A, Iwasaku M, Tokuda S, Kim YH, Takayama K

Open source

DOI
10.1016/j.jtocrr.2023.100494
Published
2023 Apr
Container
JTO clinical and research reports
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jtocrr.2023.100494,
  title = {TTF-1 Expression and Clinical Outcomes of Combined Chemoimmunotherapy in Patients With Advanced Lung Adenocarcinoma: A Prospective Observational Study.},
  author = {Katayama Y and Yamada T and Morimoto K and Fujii H and Morita S and Tanimura K and Takeda T and Okada A and Shiotsu S and Chihara Y and Hiranuma O and Yamada T and Ota T and Harada T and Hasegawa I and Yoshimura A and Iwasaku M and Tokuda S and Kim YH and Takayama K},
  year = {2023},
  journal = {JTO clinical and research reports},
  doi = {10.1016/j.jtocrr.2023.100494},
  url = {https://doi.org/10.1016/j.jtocrr.2023.100494}
}

RIS

TY  - JOUR
TI  - TTF-1 Expression and Clinical Outcomes of Combined Chemoimmunotherapy in Patients With Advanced Lung Adenocarcinoma: A Prospective Observational Study.
AU  - Katayama Y
AU  - Yamada T
AU  - Morimoto K
AU  - Fujii H
AU  - Morita S
AU  - Tanimura K
AU  - Takeda T
AU  - Okada A
AU  - Shiotsu S
AU  - Chihara Y
AU  - Hiranuma O
AU  - Yamada T
AU  - Ota T
AU  - Harada T
AU  - Hasegawa I
AU  - Yoshimura A
AU  - Iwasaku M
AU  - Tokuda S
AU  - Kim YH
AU  - Takayama K
PY  - 2023
JO  - JTO clinical and research reports
DO  - 10.1016/j.jtocrr.2023.100494
UR  - https://doi.org/10.1016/j.jtocrr.2023.100494
ER  - 

APA

Y, K., T, Y., K, M., H, F., S, M., K, T., T, T., A, O., S, S., Y, C., O, H., T, Y., T, O., T, H., I, H., A, Y., M, I., S, T., YH, K., & K, T. (2023). TTF-1 Expression and Clinical Outcomes of Combined Chemoimmunotherapy in Patients With Advanced Lung Adenocarcinoma: A Prospective Observational Study.. JTO clinical and research reports. https://doi.org/10.1016/j.jtocrr.2023.100494

Source records